FI120400B - Antineurodegeneratiivisesti vaikuttavat 10-aminoalifatyylidibents(b,f )oksepiinit - Google Patents

Antineurodegeneratiivisesti vaikuttavat 10-aminoalifatyylidibents(b,f )oksepiinit Download PDF

Info

Publication number
FI120400B
FI120400B FI960529A FI960529A FI120400B FI 120400 B FI120400 B FI 120400B FI 960529 A FI960529 A FI 960529A FI 960529 A FI960529 A FI 960529A FI 120400 B FI120400 B FI 120400B
Authority
FI
Finland
Prior art keywords
oxepin
ylmethyl
dibenz
prop
methyl
Prior art date
Application number
FI960529A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI960529A0 (fi
FI960529A (fi
Inventor
Claudia Betschart
Kaspar Zimmermann
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of FI960529A0 publication Critical patent/FI960529A0/fi
Publication of FI960529A publication Critical patent/FI960529A/fi
Application granted granted Critical
Publication of FI120400B publication Critical patent/FI120400B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02—Seven-membered rings
    • C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D313/10—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D313/14—[b,f]-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Epoxy Compounds (AREA)
FI960529A 1995-02-08 1996-02-05 Antineurodegeneratiivisesti vaikuttavat 10-aminoalifatyylidibents(b,f )oksepiinit FI120400B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH36795 1995-02-08
CH36795 1995-02-08

Publications (3)

Publication Number Publication Date
FI960529A0 FI960529A0 (fi) 1996-02-05
FI960529A FI960529A (fi) 1996-08-09
FI120400B true FI120400B (fi) 2009-10-15

Family

ID=4185416

Family Applications (1)

Application Number Title Priority Date Filing Date
FI960529A FI120400B (fi) 1995-02-08 1996-02-05 Antineurodegeneratiivisesti vaikuttavat 10-aminoalifatyylidibents(b,f )oksepiinit

Country Status (27)

Country Link
US (2) US5780500A (xx)
EP (1) EP0726265B1 (xx)
JP (2) JP3625559B2 (xx)
KR (1) KR100485538B1 (xx)
CN (1) CN1216052C (xx)
AR (1) AR004474A1 (xx)
AT (1) ATE203528T1 (xx)
AU (1) AU715245B2 (xx)
BR (1) BR9600339A (xx)
CA (1) CA2168937C (xx)
CY (1) CY2333B1 (xx)
DE (1) DE59607332D1 (xx)
DK (1) DK0726265T3 (xx)
ES (1) ES2160790T3 (xx)
FI (1) FI120400B (xx)
GR (1) GR3036656T3 (xx)
HU (1) HU229227B1 (xx)
IL (1) IL117067A (xx)
MX (1) MX9600503A (xx)
MY (1) MY113427A (xx)
NO (1) NO314356B1 (xx)
NZ (1) NZ280940A (xx)
PT (1) PT726265E (xx)
RU (1) RU2160734C2 (xx)
SA (1) SA01220313A (xx)
TW (1) TW420672B (xx)
ZA (1) ZA96960B (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840749A (en) * 1989-08-25 1998-11-24 Hoechst Marion Roussel, Inc. N-hydroxy-dibenz b,e!oxepinalkylamines, N-hydroxy-dibenz b,e!oxepinalkanoic acid amides and related heterocyclic analogues
AR008371A1 (es) * 1996-05-30 2000-01-19 Novartis Ag Una sal de adicion con acido de una 10-aminoalifatil-dibenz[b,f],oxepina, su empleo; procedimiento para su elaboracion, una 10-aminoalifatil-dibenz[b,f]oxepina, una preparacion farmaceutica que contiene dicha sal o dicha oxepina y un procedimiento para el tratamiento de enfermedades neurodegenerativ
AU3172397A (en) * 1996-06-05 1998-01-05 Novartis Ag Anti-neurodegeneratively effective xanthene derivatives
WO1998015647A1 (en) * 1996-10-08 1998-04-16 Novartis Ag Modulation of apoptosis
WO1998043621A1 (en) * 1997-03-31 1998-10-08 The Children's Medical Center Corporation Nitrosylation to inactivate apoptotic enzymes
CZ20014261A3 (cs) 1999-06-03 2002-06-12 Nippon Suisan Kaisha, Ltd. Tricyklické fúzované heterocyklické sloučeniny, způsob jejich přípravy a pouľití
WO2003057204A2 (en) * 2002-01-08 2003-07-17 Nordic Bioscience A/S Modulation of iamt (pimt or pcmt) in immune system
JP2006516580A (ja) * 2003-01-29 2006-07-06 ノバルティス アクチエンゲゼルシャフト 眼の変性疾患の処置のための１０−アミノアリファチル−ジベンズ［ｂ，ｆ］オキセピンの使用
US20050137142A1 (en) * 2003-11-03 2005-06-23 Probiodrug Ag Combinations useful for the treatment of neuronal disorders
US7906180B2 (en) * 2004-02-27 2011-03-15 Molecular Imprints, Inc. Composition for an etching mask comprising a silicon-containing material
EP1757284A1 (en) 2005-08-25 2007-02-28 Santhera Pharmaceuticals (Schweiz) AG Use of N-(dibenz(b,f)oxepin-10ylmethyl)-N-methyl-N-prop-2-ynylamine (omigapil) for the prophylaxis and/or treatment of muscular dystrophy
EP1842539A1 (en) * 2006-04-05 2007-10-10 Santhera Pharmaceuticals (Schweiz) AG Use of N- (dibenz(b,f)oxepin-10-ylmethyl)N-methyl-N-prop-2-ynylamine (omigapil) for the prophylaxis and/or treatment of congenital muscular dystrophy or myopathy resulting from collagen VI deficiency
KR20110087582A (ko) * 2010-01-26 2011-08-03 삼성전자주식회사 식각액 조성물 및 이를 이용한 식각 방법
WO2014120885A1 (en) 2013-01-30 2014-08-07 The Johns Hopkins University Treatment of drug abuse by preventing gapdh nitrosylation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3100207A (en) * 1959-07-08 1963-08-06 Smith Kline French Lab 10-aminoalkylbenzo[b,f]thiepin and -dibenz[b,f]oxepin derivatives
NL124626C (xx) * 1964-06-29
DE1493782B1 (de) * 1964-06-29 1969-12-11 Geigy Ag J R Basisch substituierte Dibenzo[b,f]-oxepine und deren nicht-toxische Salze
CH440318A (de) * 1964-11-03 1967-07-31 Geigy Ag J R Verfahren zur Herstellung von neuen Thiepin- und Oxepinderivaten
US3641056A (en) * 1970-01-06 1972-02-08 Ciba Geigy Corp 10-(aminomethyl)- and (aminoethyl)-dibenz (b f)oxepins
US3928383A (en) * 1973-06-08 1975-12-23 Hoffmann La Roche Propynylamine-substituted dibenzo{8 b,f{9 thiepins and dibenz{8 b,f{9 oxepins
IE62754B1 (en) * 1988-08-26 1995-02-22 Akzo Nv Tetracyclic antidepressants

Also Published As

Publication number Publication date
FI960529A0 (fi) 1996-02-05
ZA96960B (en) 1996-08-08
EP0726265B1 (de) 2001-07-25
NO960499D0 (no) 1996-02-07
HUP9600272A2 (en) 1997-05-28
AR004474A1 (es) 1998-12-16
GR3036656T3 (en) 2001-12-31
MX9600503A (es) 1997-01-31
BR9600339A (pt) 1998-01-27
AU4330796A (en) 1996-08-15
KR960031452A (ko) 1996-09-17
DE59607332D1 (de) 2001-08-30
NZ280940A (en) 1997-12-19
CN1137039A (zh) 1996-12-04
IL117067A (en) 2000-08-13
NO314356B1 (no) 2003-03-10
JP3625559B2 (ja) 2005-03-02
EP0726265A1 (de) 1996-08-14
DK0726265T3 (da) 2001-10-22
CA2168937A1 (en) 1996-08-09
US5780501A (en) 1998-07-14
ES2160790T3 (es) 2001-11-16
CA2168937C (en) 2009-10-20
SA01220313A (ar) 2005-12-03
NO960499L (no) 1996-08-09
RU2160734C2 (ru) 2000-12-20
CY2333B1 (en) 2004-02-06
PT726265E (pt) 2001-12-28
KR100485538B1 (ko) 2005-09-02
MY113427A (en) 2002-02-28
CN1216052C (zh) 2005-08-24
IL117067A0 (en) 1996-06-18
ATE203528T1 (de) 2001-08-15
AU715245B2 (en) 2000-01-20
HU9600272D0 (en) 1996-04-29
TW420672B (en) 2001-02-01
JP2005008646A (ja) 2005-01-13
HUP9600272A3 (en) 2000-03-28
JPH08259559A (ja) 1996-10-08
FI960529A (fi) 1996-08-09
HU229227B1 (en) 2013-09-30
US5780500A (en) 1998-07-14

Similar Documents

Publication Publication Date Title
KR100366175B1 (ko) 중추 신경계 약물로서의 나프틸아미드
FI120400B (fi) Antineurodegeneratiivisesti vaikuttavat 10-aminoalifatyylidibents(b,f )oksepiinit
JP3507494B2 (ja) タキキニン拮抗薬
KR100287749B1 (ko) 오피오이드디아릴메틸피페라진및피페리딘
DE69522676T2 (de) Naphtalen-derivate als prostaglandin i2 agonisten
US20060160875A1 (en) Matrix metalloproteinase inhibitors
JPS6049192B2 (ja) 新規置換ベンズアミド、その製造方法及びこれを有効成分とする向精神薬
JPH0649027A (ja) インドール誘導体
US6346521B1 (en) Optically active 2R, 4S benzothiepin isomer
KR20000036005A (ko) 벤즈아미딘 유도체 및 ｌｔｂ4-길항 효과를 갖는 약물로서의 이의 용도
KR100192622B1 (ko) 페네타놀아민 화합물
CA2243474C (en) Quinolin-2-(1h)-ones
KR19990063850A (ko) Nmda 길항제로서의 테트라히드로퀴놀린
EP0003893B1 (en) Novel dibenz (b,f) oxepin and dibenzo (b,f) thiepin compounds and pharmaceutically acceptable salts thereof, processes for their preparation and pharmaceutical compositions containing them
KR100196985B1 (ko) 피페리딘 유도체
JP2010024243A (ja) 緑内障および近視を処置するためのベンゾ［ｇ］キノリン誘導体
KR20020065916A (ko) Ｍｔｐ 억제제로서 치환된 피페라진 유도체
US5071858A (en) Antipsychotic benzothiopyranylamines
PL191728B1 (pl) Nowe, kwasowe sole addycyjne 10-aminoalifatyczno-dibenzo[b,f]oksepiny oraz związki pośrednie do ich wytwarzania
WO1998047877A1 (en) 2-benzoyl-1,2,3,4-tetrahydroisoquinoline-3-carboxamide derivatives and their use as inhibitors of hepatic production of apob-100
KR100382998B1 (ko) 6-메톡시-1h-벤조트리아졸-5-카르복사미드유도체,그제조방법및그것을함유하는의약조성물
CA2090635A1 (en) Substituted phenylquinazoline derivatives
CZ163693A3 (en) Novel isobutyl substituted amides of methanesulfonyl-quinolylmethoxyphenyl-cycloalkylacetic acid
US4963685A (en) Intermediates for the preparation of tetrahydroisoquino[2,1-c][1,3]benzodiazepines
EP0508004A1 (en) Phenylsulfonylalkanoic acid compounds

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: NOVARTIS AG

FG Patent granted

Ref document number: 120400

Country of ref document: FI

MA Patent expired